Dr. David Crawford: Triluron now available for knee pain
Dr. David Crawford, an orthopedic surgeon, shares that Fidia Pharma USA has announced the launch of Triluron, a hyaluronic acid-based intra-articular viscosupplement that is indicated for the treatment of pain in osteoarthritis of the knee for patients who have failed to respond adequately to the usual medications for the condition. The product contains 20mg of sodium hyaluronate, administered via intra-articular injection weekly for a total of three injections. As of press time, it has not yet been established if a single cycle of less than three injections is as effective as the regular cycle. The product is supplied in 2 ml vials or 2 ml pre-filled syringes and is intended for single use. Bilateral treatment requires the use of separate vials or syringes for each knee. The chemical formulation of Triluron is identical to the company’s five-injection regimen, Hyalgan. Studies conducted by the company show that Triluron was not inferior compared to Hyalgan based on a retrospecti...